Total Registration Budget for Medical Devices in Colombia

1. Key takeaways

Under Resolución 2025067543, the official fee for a first device registration is 321.91 UVB ≈ COP 3,898,330 (class I/IIa) or 364.36 UVB ≈ COP 4,413,000 (class IIb/III), and for IVDs COP 2,570,590 (class I/II) or COP 3,427,327 (class III). But the official fee only covers the regulator’s review service; it does not cover all the work needed to turn a Chinese document into Spanish paperwork that INVIMA can accept.

At the market level, the fully bundled registration cost is about USD 2,000–3,000 per product (market quotation range, including official fees and service fees, converted at the current exchange rate, for reference only). Converted against the official fees above, official fees usually account for less than half of that total; the difference is made up of translation and authentication, the local representative, CCAA maintenance, testing and clinical documentation, and UDI and semantic reporting. GRZAN’s assessment is that the official fee cannot be reduced; what can be optimized is the third-party cost, and the level of third-party cost depends on the first-pass acceptance rate of the dossier.

2. Legal basis

3. Expert insights

#### Translation and authentication are rigid fixed costs and cannot be remedied later

All submission documents must be in Spanish; technical or scientific information may be submitted in English with an official Spanish translation attached. This single sentence makes translation non-optional, and the quality of the official translation (traducción oficial) and the authentication chain directly affects whether a deficiency notice is issued. The deficiency response period is a practical estimate of 90 days, and one unanswered notice is treated as suspension – money saved on translation comes back doubled as time cost and a second submission.

#### The local representative is a ten-year expense, not a one-time expense

The registration certificate is valid for 10 years, and throughout that period renewals, changes, vigilance reports and notification receipt all depend on the local representative. Vigilance obligations require serious adverse events to be reported within 72 hours of becoming known and periodic reports to be submitted quarterly. Treating the local representative as someone who signs at submission means losing control at the vigilance event in year three. GRZAN recommends negotiating an annual service fee rather than a per-project arrangement.

#### Testing and UDI are the two most variable line items

Resolución 1405 de 2022 requires the UDI-DI and the semantic report, and INVIMA confirmed by official communication on March 12, 2026 that the transition period has ended and semantic reporting is fully mandatory. Companies already coded by an issuing agency such as GS1 face near-zero cost here; companies without coding must arrange code issuance and data cleansing. Testing is similar: products with an ISO 13485 system and complete verification files face limited incremental testing, while those with gaps must run supplementary work.

#### The first-pass acceptance rate determines the real unit price

Under the same budget, a product that passes once and one that goes through three rounds of deficiencies can differ in actual spending by a factor of two or more. GRZAN’s assessment: spending the budget on a pre-submission document self-review pays back better than spending it on firefighting after submission. With about 423,000 records in the INVIMA registration database and Chinese manufacturers holding about 14.4% of them (third-party statistics), Chinese companies already have benchmarks to compare against and do not need to find the path by trial and error.

4. Practical recommendations

1. Finance: build the budget in six columns – official fees, translation and authentication, local representative annual fee, CCAA, testing, UDI – and account for each separately.
2. GRZAN regulatory team: run a pre-submission completeness review at the quotation stage, outputting a gap list and an estimated remediation cost.
3. Manufacturer registration department: reuse existing ISO 13485 certificates, free sale certificates and English technical documents first, reducing duplicate production.
4. Manufacturer coding lead: confirm early whether a UDI-DI has been obtained from an issuing agency such as GS1, HIBCC, ICCBBA, IFA, Ali Health or ZIIOT.
5. Commercial: sign an annual service agreement with the local representative, covering vigilance reporting and notification relay within its scope.
6. Project manager: reserve time and cost buffers for deficiencies and reverse-schedule internal milestones from the 90-day (practical estimate) response period.

5. Verification checklist

• □ The budget is split into six columns, with official fees listed separately and attributed to Resolución 2025067543
• □ The scope and page count of the official Spanish translation have been costed
• □ The notarization and authentication chain (POA, CFS, ISO 13485) is complete and included in cost
• □ The local representative is engaged on an annual service fee, including vigilance and notification relay
• □ CCAA obtaining and 5-year maintenance costs are included
• □ The UDI-DI coding status is confirmed, with a remediation plan where coding is missing
• □ Testing and clinical documentation gaps are covered by the pre-review list
• □ A deficiency buffer of 90 days (practical estimate) is reserved

• GRZAN regulatory team

Regulatory information verified as of October 29, 2026

All conclusions published here are based on the current regulatory texts issued by the competent authority and are verified item by item before delivery.

GRZAN builds total-cost-of-registration budgets for the Colombian market, covering official fees under Resolución 2025067543, translation and authentication, local licensed-entity and importer services, CCAA, testing and UDI. For a six-column budget and a pre-submission gap review of your dossier, contact us at info@grzanglobal.com.